OMCM Stock UPDATES Omnicomm Systems Inc (OMCM) 0.1600 08/21/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicomm Systems Inc (OMCM) 0.1600 $OMCM

OmniComm Systems(R) Announces Record Contract Growth in First Half of 2014
Marketwire - Mon Aug 18, 7:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced it has achieved record contract growth through the first six months of 2014. The company has signed contracts with 3 of the top 5 global contract research organizations (CRO) during this period and 3 of the 10 top global pharmaceutical companies are now utilizing the benefits of OmniComm Systems' technology to help them advance medical research. During this period the company realized a 162% increase in total contract value as compared to the same period in 2013 with over 45% attributed to new clients.

Formedix and OmniComm Systems(R) Partnership Strengthened with the Release of Enhanced TrialMaster(R) Integration for EDC Build
PRWeb - Wed Jul 23, 11:04AM CDT
Last year, Formedix celebrated its partnership with OmniComm Systems, a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools added TrialMaster to its Transform for EDC product line. This latest, and much anticipated version of Transform for TrialMaster, is being released this week, in response to market demands for even tighter integration between these two prominent software products.

TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research
Marketwire - Mon Jul 21, 8:18AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that TFS International (TFS), the largest independent, global clinical contract research organization headquartered in Sweden, has selected TrialMaster electronic data capture (EDC) technology as its standard EDC solution for pivotal clinical trials. This whole process has been part of a company-wide initiative to provide TFS's clients around the globe with increased performance, functionality and better business decision making tools.

Leading Biotechnology Company Selects OmniComm Systems' R) TrialMaster(R)
Marketwire - Mon Jul 07, 10:32AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced that a leading biotechnology company, selected OmniComm's TrialMaster electronic data capture technology (EDC) to support three Phase III late stage clinical development studies. TrialMaster will be used for an open-labeled, multicenter, safety study and two randomized, double-blind, placebo-controlled efficacy and safety studies. OmniComm's proven technology and processes for integrating TrialMaster with other best-of-breed solutions was an important factor in selecting TrialMaster as their preferred EDC system. This leading biotechnology company will integrate TrialMaster with its preferred Interactive Response Technologies (IRT) solution. IRT solutions automate randomization and clinical supplies management and when integrated with TrialMaster EDC provides a comprehensive end-to-end solution.

OmniComm Systems(R) Signs Multi-Year Agreement With Top 5 Global CRO for TrialOne(R)
Marketwire - Wed Jun 25, 7:05AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.

OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.

Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.

OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.

OmniComm Systems, Inc. Announces Major New Release of TrialMaster(R) EDC
GlobeNewswire - Mon Dec 30, 11:28AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced the production availability of Version 4.2 of TrialMaster, its flagship product for Electronic Data Capture (EDC). This new release includes hundreds of innovative productivity and functionality enhancements, including additional features for auto-redaction for faster and more efficient centralized and risked-based monitoring, and major new features for exporting data utilizing OmniComm's award winning Export Utility.

OmniComm Systems Ranks Number 481 on Deloitte's 2013 Technology Fast 500(TM) for Fastest Growing Companies in North America
GlobeNewswire - Thu Dec 26, 10:55AM CST
OmniComm Systems, Inc. (OTC:OMCM), today announced that it was ranked number 481 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America over the past 5 years. OmniComm Systems' revenue grew 148 percent over this period.

Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.

Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.

Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.

OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.

E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e

Top 5 Pharma Company Signs 5-Year Multi-Million Dollar Agreement for OmniComm System's TrialOne Application Suite
GlobeNewswire - Mon Jun 03, 12:41PM CDT
OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne(R) suite of applications has been chosen by a top 5 pharmaceutical company to automate their global clinical trial operations and processes in all their early-phase clinics.

Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
PRWeb - Tue Apr 30, 12:25PM CDT
Formedix, a leading provider of universal design and execution tools, has added to its rapidly growing Transform for Electronic Data Capture (EDC) product line. The partnership with OmniComm Systems, a full-service, global eClinical and EDC software and services company, provides integration with TrialMaster, a leading-edge system for Electronic Data Capture and Clinical Data Management.

Intersect ENT Selects OmniComm Systems' TrialMaster(R) EDC Solution
GlobeNewswire - Mon Apr 22, 7:30AM CDT
OmniComm Systems, Inc. (OTCBB:OMCM), a leading global provider of eClinical solutions, announced today that it was selected as the EDC System of choice by Menlo Park, CA based Intersect ENT for its RESOLVE Clinical Study, a Novel In-Office Treatment option for Chronic Sinusitis Patients.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 84

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 56

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 75

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 34

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 120

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 13

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 215

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading

Top 5 Most Recently Viewed Articles

Valory Resources Enhances Leadership with Major Investment

Updated Category News Views 370

Valory Resources Secures Strategic Investment Valory Resources Inc. has made headlines by securing a strategic investment worth CAD$8.5 million from notable Canadian business figures W. Brett Wilson and Russell Wilson. This investment showcases a strong endorsement of Valory's vision, particularly regarding its steelmaking coal mining projects. New Additions to the Board...

Continue Reading
Dr. Melonie Boone Revives Boone Management Group for Modern Needs

Updated Category News Views 476

Dr. Melonie Boone Unveils a New Chapter for Boone Management Group Dr. Melonie Boone, an experienced business psychologist and former COO, has announced the exciting relaunch of Boone Management Group (BMG). This management consulting firm is set to redefine the landscape of organizational health and performance through a cutting-edge, psychology-oriented approach. With a...

Continue Reading
CPSC Addresses Recent Product Recalls for Consumer Safety

Updated Category News Views 229

Understanding Recent Product Recalls The U.S. Consumer Product Safety Commission (CPSC) has take significant steps to protect consumers from unsafe products by announcing multiple recalls. These actions aim to provide vital information that can prevent potential hazards in homes across the nation. Highlighted Product Recalls Among the recalls is a concerning announcement...

Continue Reading
Iceland Treasury Unveils New Bond Series for Market

Updated Category News Views 288

Iceland Treasury Announces New Bond Series The Icelandic Treasury has made an important announcement regarding the issuance of nine new government bond series. This move is linked to the settlement of the ÍL Fund, previously known as the Housing Financing Fund. Investors and financial analysts will want to pay close attention to these developments as they can have...

Continue Reading
Hormel Foods’ Significant Contribution to Wildfire Relief Efforts

Updated Category News Views 241

Hormel Foods’ Commitment to Community Support In response to the devastations caused by wildfires, Hormel Foods Corporation (NYSE: HRL) is stepping up to lend a hand. The company has made a pledge to support disaster relief efforts as California faces ongoing challenges brought on by these fires. This initiative underscores Hormel Foods' commitment to the well-being of...

Continue Reading